Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
You must be logged in to use this feature
{{ loginError }}
Select categories you would like to watch. Updates to this gene will be sent to {{ username }}
x
Send Message
Gene: Irak1bp1 (interleukin-1 receptor-associated kinase 1 binding protein 1) Rattus norvegicus
Analyze
Symbol:
Irak1bp1
Name:
interleukin-1 receptor-associated kinase 1 binding protein 1
RGD ID:
1305012
Description:
Predicted to enable signaling adaptor activity. Predicted to be involved in positive regulation of canonical NF-kappaB signal transduction. Predicted to be located in cytoplasm and nucleus. Orthologous to human IRAK1BP1 (interleukin 1 receptor associated kinase 1 binding protein 1); INTERACTS WITH 17beta-estradiol; 17beta-estradiol 3-benzoate; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
interleukin-1 receptor-associated kinase 1-binding protein 1; LOC300862
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 92,608,468 - 92,628,377 (+) NCBI GRCr8 GRCr8 GRCr8 GRCr8 Ensembl 8 92,611,843 - 92,628,377 (+) Ensembl GRCr8 mRatBN7.2 8 83,731,512 - 83,748,289 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 83,731,507 - 83,748,289 (+) Ensembl mRatBN7.2 UTH_Rnor_SHR_Utx 8 89,332,889 - 89,349,394 (+) NCBI UTH_Rnor_SHR_Utx UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 87,562,551 - 87,578,912 (+) NCBI UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 85,425,138 - 85,441,643 (+) NCBI UTH_Rnor_WKY_Bbb_1.0 UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 90,343,307 - 90,360,085 (+) NCBI Rnor_6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 90,343,154 - 90,360,086 (+) Ensembl rn6 Rnor6.0 Rnor_5.0 8 89,871,572 - 89,888,350 (+) NCBI Rnor_5.0 Rnor_5.0 rn5 RGSC_v3.4 8 87,956,612 - 87,972,991 (+) NCBI RGSC_v3.4 RGSC_v3.4 rn4 Celera 8 83,395,203 - 83,411,558 (+) NCBI Celera RGSC_v3.1 8 87,971,361 - 87,992,732 (+) NCBI Cytogenetic Map 8 q31 NCBI
JBrowse:
Imported Disease Annotations - ClinVar
Irak1bp1 Rat DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES ISO RGD:15151227|RGD:155909985|RGD:155917711|RGD:155941657|RGD:155946743|RGD:155994000|RGD:156001386|RGD:156086774|RGD:156086800|RGD:156113993|RGD:156168282|RGD:156199250|RGD:156199284|RGD:156206084|RGD:156218440|RGD:156223036|RGD:156223204|RGD:156256772|RGD:156268314|RGD:156279616|RGD:156285069|RGD:156310091|RGD:156311384|RGD:156313510|RGD:156356438|RGD:156374182|RGD:156390259|RGD:156398887|RGD:156412232|RGD:156434275|RGD:401920707|RGD:402468189|RGD:402487821|RGD:402506967|RGD:404986306|RGD:405062539|RGD:405122933|RGD:405123442|RGD:405123801|RGD:405219665|RGD:405237749|RGD:405246767|RGD:405254476|RGD:408368305|RGD:408368324|RGD:408368355|RGD:408368502|RGD:408368632|RGD:408368865|RGD:408369028|RGD:408378350 9068941 ClinVar Annotator: match by term: DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHISM | ClinVar Annotator: more ... ClinVar PMID:28492532
Imported Disease Annotations - CTD
Only show annotations with direct experimental evidence (0 objects hidden)
Irak1bp1 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRAK1BP1 mRNA CTD PMID:22079256 Irak1bp1 Rat (1->4)-beta-D-glucan multiple interactions ISO Irak1bp1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IRAK1BP1 mRNA CTD PMID:36331819 Irak1bp1 Rat 17beta-estradiol multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of IRAK1BP1 mRNA CTD PMID:30165855 Irak1bp1 Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA CTD PMID:32741896 Irak1bp1 Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA CTD PMID:32741896 Irak1bp1 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Irak1bp1 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression more ... CTD PMID:25975270 Irak1bp1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IRAK1BP1 mRNA CTD PMID:33387578 Irak1bp1 Rat 4,4'-diaminodiphenylmethane decreases expression ISO Irak1bp1 (Mus musculus) 6480464 4,4'-diaminodiphenylmethane results in decreased expression of IRAK1BP1 mRNA CTD PMID:18648102 Irak1bp1 Rat acrylamide decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Acrylamide results in decreased expression of IRAK1BP1 mRNA CTD PMID:32763439 Irak1bp1 Rat all-trans-retinoic acid decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of IRAK1BP1 mRNA CTD PMID:33167477 Irak1bp1 Rat antirheumatic drug increases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of IRAK1BP1 mRNA CTD PMID:24449571 Irak1bp1 Rat aristolochic acid A decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of IRAK1BP1 mRNA CTD PMID:33212167 Irak1bp1 Rat azathioprine decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Azathioprine results in decreased expression of IRAK1BP1 mRNA CTD PMID:22623647 Irak1bp1 Rat benzo[a]pyrene decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of IRAK1BP1 mRNA CTD PMID:20106945|PMID:21632981 Irak1bp1 Rat benzo[a]pyrene decreases expression ISO Irak1bp1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of IRAK1BP1 mRNA CTD PMID:19770486|PMID:22228805 Irak1bp1 Rat bisphenol A increases expression ISO IRAK1BP1 (Homo sapiens) 6480464 bisphenol A results in increased expression of IRAK1BP1 mRNA CTD PMID:32387340 Irak1bp1 Rat bisphenol A increases expression ISO Irak1bp1 (Mus musculus) 6480464 bisphenol A results in increased expression of IRAK1BP1 mRNA CTD PMID:32156529 Irak1bp1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IRAK1BP1 mRNA CTD PMID:34947998|PMID:41034487 Irak1bp1 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of IRAK1BP1 mRNA CTD PMID:19167457 Irak1bp1 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of IRAK1BP1 mRNA CTD PMID:33453195 Irak1bp1 Rat CGP 52608 multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to IRAK1BP1 gene] CTD PMID:28238834 Irak1bp1 Rat chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of IRAK1BP1 mRNA CTD PMID:18668222 Irak1bp1 Rat chromium(6+) affects expression ISO IRAK1BP1 (Homo sapiens) 6480464 chromium hexavalent ion affects the expression of IRAK1BP1 mRNA CTD PMID:30690063 Irak1bp1 Rat copper atom increases expression EXP 6480464 Copper results in increased expression of IRAK1BP1 mRNA CTD PMID:30556269 Irak1bp1 Rat copper(0) increases expression EXP 6480464 Copper results in increased expression of IRAK1BP1 mRNA CTD PMID:30556269 Irak1bp1 Rat crocidolite asbestos decreases expression ISO Irak1bp1 (Mus musculus) 6480464 Asbestos, Crocidolite results in decreased expression of IRAK1BP1 mRNA CTD PMID:29279043 Irak1bp1 Rat dorsomorphin multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Irak1bp1 Rat doxorubicin decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of IRAK1BP1 mRNA CTD PMID:29803840 Irak1bp1 Rat ethanol increases expression ISO Irak1bp1 (Mus musculus) 6480464 Ethanol results in increased expression of IRAK1BP1 mRNA CTD PMID:30319688 Irak1bp1 Rat furan increases expression EXP 6480464 furan results in increased expression of IRAK1BP1 mRNA CTD PMID:25539665 Irak1bp1 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IRAK1BP1 mRNA CTD PMID:33387578 Irak1bp1 Rat graphene oxide decreases expression ISO Irak1bp1 (Mus musculus) 6480464 graphene oxide results in decreased expression of IRAK1BP1 mRNA CTD PMID:33227293 Irak1bp1 Rat lead(0) affects expression ISO IRAK1BP1 (Homo sapiens) 6480464 Lead affects the expression of IRAK1BP1 mRNA CTD PMID:28903495 Irak1bp1 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of IRAK1BP1 gene CTD PMID:35440735 Irak1bp1 Rat methyl methanesulfonate increases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of IRAK1BP1 mRNA CTD PMID:23649840 Irak1bp1 Rat N(4)-hydroxycytidine decreases expression ISO Irak1bp1 (Mus musculus) 6480464 N(4)-hydroxycytidine results in decreased expression of IRAK1BP1 mRNA CTD PMID:37748715 Irak1bp1 Rat o-anisidine decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 2-anisidine results in decreased expression of IRAK1BP1 mRNA CTD PMID:28089782 Irak1bp1 Rat okadaic acid decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of IRAK1BP1 mRNA CTD PMID:38832940 Irak1bp1 Rat ozone multiple interactions ISO Irak1bp1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... CTD PMID:34911549 Irak1bp1 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IRAK1BP1 mRNA CTD PMID:32479839 Irak1bp1 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of IRAK1BP1 mRNA CTD PMID:33387578 Irak1bp1 Rat pentane-2,3-dione decreases expression EXP 6480464 2,3-pentanedione results in decreased expression of IRAK1BP1 mRNA CTD PMID:25710175 Irak1bp1 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Irak1bp1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IRAK1BP1 mRNA CTD PMID:36331819 Irak1bp1 Rat phenylmercury acetate decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of IRAK1BP1 mRNA CTD PMID:26272509 Irak1bp1 Rat phenylmercury acetate multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Irak1bp1 Rat pirinixic acid multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Irak1bp1 Rat pirinixic acid increases expression ISO Irak1bp1 (Mus musculus) 6480464 pirinixic acid results in increased expression of IRAK1BP1 mRNA CTD PMID:20813756 Irak1bp1 Rat potassium chromate multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRAK1BP1 mRNA CTD PMID:22079256 Irak1bp1 Rat potassium chromate increases expression ISO IRAK1BP1 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of IRAK1BP1 mRNA CTD PMID:22714537 Irak1bp1 Rat potassium chromate decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of IRAK1BP1 mRNA CTD PMID:22079256 Irak1bp1 Rat quercetin decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Quercetin results in decreased expression of IRAK1BP1 mRNA CTD PMID:21632981 Irak1bp1 Rat quinolin-8-ol decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Oxyquinoline results in decreased expression of IRAK1BP1 mRNA CTD PMID:21632981 Irak1bp1 Rat resorcinol decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 resorcinol results in decreased expression of IRAK1BP1 mRNA CTD PMID:22623647 Irak1bp1 Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of IRAK1BP1 mRNA CTD PMID:19013527 Irak1bp1 Rat SB 431542 multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Irak1bp1 Rat sodium arsenate increases expression ISO Irak1bp1 (Mus musculus) 6480464 sodium arsenate results in increased expression of IRAK1BP1 mRNA CTD PMID:39847705 Irak1bp1 Rat sodium arsenite affects methylation ISO IRAK1BP1 (Homo sapiens) 6480464 sodium arsenite affects the methylation of IRAK1BP1 gene CTD PMID:28589171 Irak1bp1 Rat sodium arsenite decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of IRAK1BP1 mRNA CTD PMID:38568856 Irak1bp1 Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of IRAK1BP1 mRNA CTD PMID:19281266 Irak1bp1 Rat sunitinib increases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Sunitinib results in increased expression of IRAK1BP1 mRNA CTD PMID:31533062 Irak1bp1 Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA CTD PMID:32741896 Irak1bp1 Rat thiram decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 Thiram results in decreased expression of IRAK1BP1 mRNA CTD PMID:38568856 Irak1bp1 Rat titanium dioxide decreases methylation ISO Irak1bp1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of IRAK1BP1 gene CTD PMID:35295148 Irak1bp1 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of IRAK1BP1 mRNA CTD PMID:33387578 Irak1bp1 Rat trichostatin A decreases expression ISO IRAK1BP1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of IRAK1BP1 mRNA CTD PMID:26272509 Irak1bp1 Rat trichostatin A multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Irak1bp1 Rat triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of IRAK1BP1 mRNA CTD PMID:30589522 Irak1bp1 Rat triphenyl phosphate affects expression ISO IRAK1BP1 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of IRAK1BP1 mRNA CTD PMID:37042841 Irak1bp1 Rat zinc atom multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of IRAK1BP1 mRNA CTD PMID:18593933 Irak1bp1 Rat zinc(0) multiple interactions ISO IRAK1BP1 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of IRAK1BP1 mRNA CTD PMID:18593933
QTLs in Region (GRCr8)
1300177 Cm2 Cardiac mass QTL 2 3.65 heart mass (VT:0007028) heart weight (CMO:0000017) 8 63141536 109261840 Rat 1549909 Stresp11 Stress response QTL 11 6.83 0.0019 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 8 82352698 127352698 Rat 12879878 Bw183 Body weight QTL 183 0.001 body mass (VT:0001259) body weight (CMO:0000012) 8 62848139 107848139 Rat 1549908 Neudeg1 Neurodegradation QTL 1 5.5 0 nervous system integrity trait (VT:0010566) logarithm of the ratio of the lesioned side motor neuron count to contralateral side motor neuron count (CMO:0001986) 8 58337123 103337123 Rat 12879879 Cm99 Cardiac mass QTL 99 0.001 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 62848139 107848139 Rat 1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 49849908 118871671 Rat 9590292 Uminl3 Urine mineral level QTL 3 3.62 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 8 80768445 125768445 Rat 1331804 Cm30 Cardiac mass QTL 30 3.77443 heart mass (VT:0007028) heart wet weight (CMO:0000069) 8 62970527 107970527 Rat 1578769 Uae31 Urinary albumin excretion QTL 31 3.3 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 39106363 103375781 Rat 1298079 Activ2 Activity QTL 2 9.5 0.000001 voluntary movement trait (VT:0003491) rearing measurement (CMO:0001515) 8 50763951 95763951 Rat 12879880 Cm100 Cardiac mass QTL 100 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 8 62848139 107848139 Rat 12879881 Cm101 Cardiac mass QTL 101 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 8 62848139 107848139 Rat 12879882 Am8 Aortic mass QTL 8 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 8 62848139 107848139 Rat 12879883 Kidm65 Kidney mass QTL 65 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 62848139 107848139 Rat 70161 Bp62 Blood pressure QTL 62 2.9 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 51589699 99045312 Rat 71120 Niddm21 Non-insulin dependent diabetes mellitus QTL 21 3.73 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 8 66992095 111992095 Rat 1358912 Bw51 Body weight QTL 51 2.95 body mass (VT:0001259) body weight (CMO:0000012) 8 60248093 105248093 Rat 634332 Pia18 Pristane induced arthritis QTL 18 4 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 8 84192326 132782436 Rat 1578765 Klgr1 Kidney lesion grade QTL 1 3.3 0.0001 kidney morphology trait (VT:0002135) organ lesion measurement (CMO:0000677) 8 39106363 103375781 Rat 1300171 Bp184 Blood pressure QTL 184 3.66 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 8 79394435 132782436 Rat 1578755 Pur5 Proteinuria QTL 5 3.3 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 8 39106258 103375958 Rat 631210 Bw3 Body weight QTL3 5.9 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 8 61019838 121662124 Rat 2293697 Bmd39 Bone mineral density QTL 39 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 8 62848139 107848139 Rat 8662823 Vetf5 Vascular elastic tissue fragility QTL 5 1.9 artery integrity trait (VT:0010639) patent ductus arteriosus score (CMO:0002566) 8 63404444 108404444 Rat 1358896 Bp262 Blood pressure QTL 262 2.89 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 35464071 107982864 Rat 1331837 Bw23 Body weight QTL 23 4.19 0.00007 body mass (VT:0001259) body weight (CMO:0000012) 8 55428416 107963099 Rat 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 3.53 0.0004 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 62963099 107963099 Rat 8694446 Bw170 Body weight QTL 170 12.07 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 8 80768445 125768445 Rat 631650 Stl6 Serum triglyceride level QTL 6 4 0.0019 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 70041301 121080908 Rat 1331769 Rf39 Renal function QTL 39 3.871 urine output (VT:0003620) timed urine volume (CMO:0000260) 8 50763951 107970527 Rat 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 3.8 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 8 68690349 119799881 Rat 1358906 Bp253 Blood pressure QTL 253 4 0.0004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 49610204 94610204 Rat 10450865 Bw175 Body weight QTL 175 4.1 total fat pad mass (VT:0015008) adipose tissue molecular composition measurement (CMO:0000484) 8 84192326 129192326 Rat 1358907 Cm40 Cardiac mass QTL 40 1.89 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 35464071 107982864 Rat 70197 BpQTLcluster8 Blood pressure QTL cluster 8 3.482 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 55428333 127966348 Rat 2316950 Scl66 Serum cholesterol level QTL 66 4.1 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 39106363 114525825 Rat 1582254 Kidm31 Kidney mass QTL 31 3 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 8 49245178 94245178 Rat 2300181 Bmd55 Bone mineral density QTL 55 5.7 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 85348065 130348065 Rat 724540 Uae8 Urinary albumin excretion QTL 8 5 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 8 39106258 103375958 Rat 10402857 Bp380 Blood pressure QTL 380 0.95 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 62848139 107848139 Rat 1358892 Kidm26 Kidney mass QTL 26 3.69 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 35464071 107982864 Rat 631664 Hcar3 Hepatocarcinoma resistance QTL 3 2.9 0.0005 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 8 62982864 107982864 Rat 2301402 Bp316 Blood pressure QTL 316 0.005 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 62848139 107848139 Rat 1582243 Bw66 Body weight QTL 66 3.4 0.0048 body mass (VT:0001259) body weight (CMO:0000012) 8 49245178 94245178 Rat 8694200 Abfw4 Abdominal fat weight QTL 4 9.07 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 8 80768445 125768445 Rat 8694392 Bw161 Body weight QTL 161 8.06 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 8 80768445 125768445 Rat 61437 Cia6 Collagen induced arthritis QTL 6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 8 91340911 131690273 Rat